Galectin-3 as a Biomarker in Patients With Chagas Disease
Learn more about:
Related Clinical Trial
An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother’s and Baby’s Health
SBRT in Chagas Disease Ventricular Tachycardia
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
New Scheme for Treatment With Benznidazole
Outcomes of an Anticoagulation Clinic in an University Hospital
Cardiac Rehabilitation in Chagas Heart Failure
Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease
Exercise Training in Chagas Cardiomyopathy
Genetic Architecture of Heart Disease in Rural Brazil
Physical Exercise Program in Chronic Chagas Heart Disease
Pharmacokinetic Drug-Drug Interaction Study
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure
Abbott ESA Chagas Assay Post-Market Study
Longitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project)
Population Pharmacokinetics Study of Benznidazole in Children With Chagas’Disease
Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction
Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
Colchicine for Patients With ChagasĀ“ Disease( B1 Stage)
Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg
Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas’ Patients
Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas’ Patients
Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas’ Patients – Dietary Habits Study
BENDITA BEnznidazole New Doses Improved Treatment and Associations
New Therapies and Biomarkers for Chagas Infection
Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy
Selenium Treatment and Chagasic Cardiopathy (STCC)
Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease
Congenital Transmission of Lineages I and II of Trypanosoma Cruzi
Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease
Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease
Prospective Study of Benznidazole for Chagas’ Disease Children With Chronic Indeterminate Chagas Disease
Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease
Prospective Study of a Pediatric Nifurtimox Formulation for Chagas’ Disease
Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children
Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment
New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
MicroRNAs as Biomarkers in Patients With Chagas Disease
Galectin-3 as a Biomarker in Patients With Chagas Disease
Syndecan-4 as a Biomarker in Patients With Chagas Disease
Population Pharmacokinetics of Benznidazole in Children With Chagas Disease
Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease
Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina
Assessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas Disease